Fundz

Checkmate Pharmaceuticals, Inc. reported raising $11 Million in an initial SEC Form D filing, from an offering of $22 Million

PRIVATEDec 12, 2018$11M of $22M raised

Amount Raised

$11 Million

$11 Million sold, per SEC Form D (first sale Dec 12, 2018)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareScience And Engineering

Quick answer

Checkmate Pharmaceuticals, Inc. raised $11 Million in a funding round, dated December 12, 2018. Checkmate Pharmaceuticals, Inc. is based in Cambridge, Massachusetts, United States.

How much did Checkmate Pharmaceuticals, Inc. raise?
Checkmate Pharmaceuticals, Inc. raised $11 Million in a funding round on December 12, 2018.
What does Checkmate Pharmaceuticals, Inc. do?
Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer.
Where is Checkmate Pharmaceuticals, Inc. based and how big is it?
Checkmate Pharmaceuticals, Inc. is based in Cambridge, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Science And Engineering around the same time

Companies in the same sectors as Checkmate Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Purple Biotech raised $6M on January 24, 2019.
  • Monteris Medical raised $11M on January 22, 2019.
  • Gestalt Diagnostics raised $300K on January 17, 2019.
  • BioCardia raised $4M (Seed) on January 7, 2019.
  • vTv Therapeutics Inc. raised $1.5M (Seed) on January 4, 2019.
  • CryoPort raised $25M on December 28, 2018.

Who to call at Checkmate Pharmaceuticals, Inc., and when

A new round usually means Checkmate Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Checkmate Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Checkmate Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Checkmate Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Checkmate Pharmaceuticals, Inc.

Location

245 MAIN STREET, 2ND FLOOR

Cambridge, Massachusetts, United States

About

Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer. Checkmate Pharmaceuticals’ product candidate, vidutolimod (CMP-001), is an advanced generation Toll-like receptor 9 (TLR9) agonist, delivered as a biologic virus-like particle utilizing a CpG-A oligodeoxynucleotide as a key component, designed to trigger the body’s innate immune system to attack tumors in combination with other therapies. Information regarding Checkmate Pharmaceuticals is available at www.checkmatepharma.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Checkmate Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Checkmate Pharmaceuticals, Inc.'s next move

See what Strategic adds

Checkmate Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.